1688-0420
1688-0420
S1688-04202017000300264
10.29277/ruc/32.3.7
00
12
2017
00
12
2017
32
3
264
276
[
2015
131
9
9
771-3
]
[
2016
387
10027
10027
1513-30
]
[
2015
183
82-8
]
[
1974
34
1
1
29-34
]
[
2007
93
9
9
1137-46
]
[
2013
77
9
9
2209-17
]
[
2009
93
1 Supl 1
1 Supl 1
3-70
]
[
2014
63
12
12
1123-33
]
[
2017
9
1
1
16-8
]
[
2013
10
4
4
330-6
]
[
2001
24
9
9
1614-9
]
[
2007
115
25
25
3213-23
]
[
2001
38
2
2
421-8
]
[
2008
121
9
9
748-57
]
[
1972
30
6
6
595-602
]
[
2004
27
3
3
699-703
]
[
2008
26
3
3
203-13
]
[
2005
46
6
6
1019-26
]
[
2006
92
3
3
296-300
]
[
2011
36
2
2
102-15
]
[
2017
2017
7p
]
[
2010
11
1
1
31-9
]
[
2016
7
125
]
[
2012
110
9 Suppl
9 Suppl
58B-68B
]
[
2008
8
3
3
243-8
]
[
2010
18
10
10
1895-901
]
[
2014
57
4
4
660-71
]
[
2016
12
3
3
144-53
]
[
2005
26
908-17
]
[
2002
109
1
1
121-30
]
[
2017
6
2
2
140-5
]
[
2016
202
40-3
]
[
2015
6
7
7
943-60
]
[
2000
101
16
16
1899-906
]
[
1995
26
5
5
1235-41
]
[
2012
17
2
2
79-84
]
[
2014
15
7
7
736-46
]
[
2005
28
3
3
702-7
]
[
2014
5
364
]
[
2011
32
^s1
^s1
1
712
]
[
2005
111
310-4
]
[
2014
5
5
5
601-5
]
[
2010
95
2
2
513-21
]
[
2009
94
10
10
3687-95
]
[
2003
107
3
3
448-54
]
[
New York Heart Failure Consortium
2004
43
8
8
1432-8
]
[
van der Leeuw J.Beulens JW.van Dieren S.Schalkwijk CG.Glatz JF.Hofker MH
2016
5
6
6
]
[
2009
15
5
5
377-84
]
[
2010
33
9
9
559-64
]
[
2016
16
242
]
[
2017
32
3
3
404-21
]
[
2014
16
2
2
449
]
[
2017
16
10
]
[
2007
115
1
1
114-26
]
[
2003
348
5
5
383-93
]
[
2008
358
6
6
580-91
]
[
2016
59
11
11
2298-307
]
[
2007
3
3
3
204-11
]
[
2013
36
10
10
3297-304
]
[
2009
32
11
11
2068-74
]
[
2007
55
5
5
230-6
]
[
2008
359
1577-89
]
[
2016
133
24
24
2459-502
]
[
2013
6
3
3
395-402
]
[
2017
51
7
7
570-6
]
[
2015
17
12
12
1180-93
]
[
EMPA-REG OUTCOME Investigators
2015
373
2117-28
]
[
EMPA-REG OUTCOME trial investigators
2016
37
19
19
1526-34
]
[
Cholesterol Treatment Trialists' Collaborators
2008
371
9607
9607
117-25
]
[
CARDS investigators
2004
364
9435
9435
685-96
]
[
2006
29
6
6
1220-6
]
[
2007
8
480-6
]
[
Heart Outcomes Prevention Evaluation Study Investigators
2000
355
9200
9200
253-9
]
[
2016
29
8
8
969-75
]
[
2012
125
19
19
2323-33
]
[
2017
65
4
4
347-53
]
[
2014
9
5
5
]
[
2014
6
1
1
80
]
[
2010
40
2
2
148-54
]
[
2012
55
5
5
1544-53
]
[
Q-SYMBIO Study Investigators
2014
2
6
6
641-9
]
[
2006
444
7117
7117
337-42
]
[
Van de Weijer T.Goossens GH
2011
14
5
5
612-22
]
[
2010
298
3
3
H833-43
]
[
2013
31
9
9
1819-27
]
[
2014
95
2
2
63-71
]
[
2016
41
1
1
26-32
]
[
2017
9
1
1
27
]
[
2011
106
3
3
383-9
]
[
2014
2014
8p
]
[
2015
59
1
1
147-59
]